Hung Q. Doan, M.D., Ph.D.
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Dermatology, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual Faculty Appointment, Dermatology, The University of Texas Health Science Center at Houston, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Faculty Appointment, Dermatology, The University of Texas Health Science Center at Houston, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | The University of Texas Medical Branch, Galveston, Texas, US, MD |
| 2013 | The University of Texas Medical Branch, Galveston, Texas, US, PhD, Ph.D |
| 2005 | The University of Texas, Austin, Texas, US, BA, BA |
| 2005 | The University of Texas, Austin, Texas, US, Bio, BS |
Postgraduate Training
| 2014-2017 | Clinical Residency, Dermatology, McGovern Medical School at UT Health, Houston, Texas |
| 2013-2014 | Clinical Internship, Internal Medicine, Houston Methodist Hospital, Houston, Texas |
Licenses & Certifications
| 2022 | Medical License |
| 2017 | Diplomate, American Board of Dermatology |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Dermatology, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2018 - 2025
Assistant Professor, Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, 2017 - 2018
Intramural Institutional Committee Activities
Alternate Member, Dermatology, Credentialing Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
Member, Mid-Career Faculty Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Dermatology Chair Search Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, University of Texas MD Anderson Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Division of Internal Medicine Faculty Excellence Awards Review Committee, The University of Texas MD Anderson Cancer Center, 2020
Editorial Activities
Reviewer, Journal of the American Academy of Dermatology, 2026 - Present
Editorial Fellowship, Journal of the American Academy of Dermatology, 2025 - 2026
Honors & Awards
| 2025 | Incentive for Salary Awards (ISA), UT MD Anderson |
| 2012 | Rose and Harry Walk Research Award |
| 2012 | John P. McGovern Practice of Medicine Professionalism Essay Award |
| 2011 | The Biological Chemistry Student Organization Award |
| 2011 | Kay and Cary Cooper, Ph.D. Scholarship |
| 2010 | Shirley Patricia Parker Scholarship |
| 2009 | Arthur V. Simmang Graduate School Scholarship |
| 2009 | Marianne Blum, Ph.D. Endowed Scholarship |
| 2005 | Phi Beta Kappa, Alpha of Texas |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Merkel Cell Carcinoma: State of the Science and Therapeutics Update. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- Where Dermatology and COVID-19 Intersect: Teledermatology Opportunities and Lessons. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2023. Merkel Cell Carcinoma- Therapeutics Update. Conference. Texas Dermatological Society Fall Meeting. San Antonio, TX, US.
National Presentations
- 2016. "Activation of cell signaling pathways in polyomavirus-mediated cutaneous carcinogenesis". Invited. Society for Investigative Dermatology, US.
- 2016. "Gene expression analysis of Merkel cell polyomavirus small-T antigen demonstrates metabolism pathway alterations". Invited. Society for Investigative Dermatology, US.
- 2016. "Identification of potential therapeutic targets for Merkel cell carcinoma". Invited. Texas Dermatological Society, US.
- 2009. "Toll Like Receptor 4 Activities Akt in a Time-Dependent Manner". Invited. Academic Surgical Congress, US.
Formal Peers
- 2019. Cancer immunotherapy. Visiting. Houston, TX, US.
- 2019. Potpurri, admonitions, and adages. Visiting. Houston, TX, US.
- 2018. Kodachromes. Visiting. Houston, TX, US.
- 2018. Board Review. Visiting. Houston, TX, US.
- 2017. Cancer immunotherapy. Visiting. Houston, TX, US.
Grant & Contract Support
| Date: | 2023 - 2028 |
| Title: | Geospatial Approaches to Melanoma Early Detection - The GAMED Project |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP230036 |
| Date: | 2022 - 2025 |
| Title: | Cutaneous Squamous Cell Carcinoma (cSCC): Defining the Precancer Atlas of Skin Actinic Keratoses and Squamous Cell Carcinomas at the Single-Cell Level |
| Funding Source: | University of Texas MD Anderson Cancer Center |
| Role: | Collaborator |
| ID: | 2027-0897 |
| Date: | 2021 - 2022 |
| Title: | Project ECHO: Early Melanoma Detection Educational Network |
| Funding Source: | Melanoma Moonshot Grant |
| Role: | Collaborator |
Selected Publications
Peer-Reviewed Articles
- Duque-Clavijo, V, Doan, HQ, Das, JA, Tyring, SK. Sweet syndrome successfully treated with upadacitinib. JAAD Case Reports 65:179-182, 2025. e-Pub 2025. PMID: 41143222.
- Ahmad, N, Bartley, BR, Zhang, S, Taylor, MM, Schrader, K, Zhang, K, Doan, HQ, Bauer, CX, Nelson, KC, Cofer, J. Assessing Sun Protection Policies in Texas School Districts Located in Counties With the Lowest and Highest Melanoma Risk. Cancer Control 32, 2025. e-Pub 2025. PMID: 40550782.
- Kim, JH, Burningham, KM, Sedrak, M, Doan, HQ, Tyring, SK. Co-occurring Melanoma in an Active Area of Vitiligo in Skin of Color. Journal of Drugs in Dermatology 24(2):205-206, 2025. e-Pub 2025. PMID: 39913215.
- Zhang, K, Taylor, MM, Hunyadi, JV, Doan, HQ, Adamson, AS, Miller, P, Nelson, KC, Bauer, CX. Examining Demographic, Geographic, and Temporal Patterns of Melanoma Incidence in Texas From 2000 to 2018. JMIR Cancer 11, 2025. e-Pub 2025. PMID: 40315814.
- Narayanan, D, Tran, T, Duque-Clavijo, V, Doan, HQ, Tyring, SK. Successful Treatment of Comorbid SAPHO Syndrome and Hidradenitis Suppurativa with Upadacitinib. Acta Dermato-Venereologica 105, 2025. e-Pub 2025. PMID: 41403264.
- Narayanan, D, Bartley, BR, Landes, JR, Moore, SA, Kulkarni, V, He, Q, Simonette, R, Doan, HQ, Rady, PL, Tyring, SK. The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines. Archives of Dermatological Research 316(6), 2024. e-Pub 2024. PMID: 38822924.
- Madrigal K, Morris L, Zhang K, Nelson E, Tran T, Galindez M, Duan Z, Adamson AS, Zhao H, Doan HQ, Taylor MM, Bauer C, Nelson KC. Persistent poverty and incidence-based melanoma mortality in Texas. Cancer Causes Control 35(6):973-979, 2024. e-Pub 2024. PMID: 38421511.
- Haff, PL, Jacobson, A, Taylor, MM, Schandua, HP, Farris, D, Doan, HQ, Nelson, KC. The New Media Landscape and Its Effects on Skin Cancer Diagnostics, Prognostics, and Prevention. JMIR Dermatology 7, 2024. e-Pub 2024. PMID: 38587890.
- Landes JR, Bartley BR, Moore SA, He Q, Simonette R, Rady PL, Doan HQ, Tyring SK. Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines. Clin Exp Dermatol 48(8):903-908, 2023. e-Pub 2023. PMID: 37191210.
- Wilmas KM, Patel J, Silapunt S, Doan HQ, Migden MR. The Use of a Dehydrated Complete Human Placental Membrane Allograft for Mohs Surgical Defects of the Nose. Dermatol Surg 49(4):343-347, 2023. e-Pub 2023. PMID: 36799879.
- Tran T, Cyr PR, Verdieck A, Lu MD, Ahrns HT, Berry EG, Bowen W, Braun RP, Cusick-Lewis JM, Doan HQ, Donohue VL, Erlich DR, Ferris LK, Harkemanne E, Hartman RI, Holt J, Jaimes N, Joslin TA, Kabaeva Z, Liebman TN, Ludzik J, Marghoob AA, Simpson I, Stein JA, Stulberg DL, Tromme I, Turnquist MJ, Usatine RP, Walker AM, Walker BL, West RF, Wilson ML, Witkowski A, Wu DJ, Seiverling EV, Nelson KC. Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care. J Am Board Fam Med 36(1):25-38, 2023. e-Pub 2023. PMID: 36759132.
- Nelson KC, Seiverling EV, Gonna N, Berry E, Stoos E, Dorsey CN, Sepulveda S, Vazquez G, Doan HQ, Haydu LE. A Pilot Educational Intervention to Support Primary Care Provider Performance of Skin Cancer Examinations. J Cancer Educ, 2023. e-Pub 2022. PMID: 35013902.
- Moore SA, Narayanan D, Simonette RA, Bartley BR, Doan HQ, Rady PL, Tyring SK. Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma. Clin Exp Dermatol 47(7):1354-1357, 2022. e-Pub 2022. PMID: 35120268.
- Bartley BR, Simonette RA, Rady PL, Doan HQ, Tyring SK. Molecular evidence for selinexor as a treatment for Merkel cell polyomavirus (MCPyV)-positive Merkel cell carcinoma. Int J Dermatol, 2022. e-Pub 2022. PMID: 35094380.
- Wu JH, Limmer AL, Narayanan D, Doan HQ, Simonette RA, Rady PL, Tyring SK. The novel AKT inhibitor Afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth. Clin Exp Dermatol 46(8):1551-1554, 2021. e-Pub 2021. PMID: 34115902.
- Doan HQ, Chen L, Nawas Z, Lee HH, Silapunt S, Migden M. Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma. Oncotarget 12(20):2089-2100, 2021. e-Pub 2021. PMID: 34611482.
- Wu JH, Limmer AL, Narayanan D, Doan HQ, Simonette RA, Rady PL, Tyring SK. The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth. Clinical and Experimental Dermatology 46(8):1551-1554, 2021. e-Pub 2021. PMID: 34115902.
- Gupta R, Simonette RA, Doan HQ, Rady PL, Tyring SK. Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment. Br J Dermatol 184(6):1185-1187, 2021. e-Pub 2021. PMID: 33403670.
- Gupta R, Simonette RA, Doan HQ, Rady PL, Tyring SK. Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment. British Journal of Dermatology 184(6):1185-1187, 2021. e-Pub 2021. PMID: 33403670.
- Gupta R, Ibraheim MK, Doan HQ. Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray. J Am Acad Dermatol 83(1):168-169, 2020. e-Pub 2020. PMID: 32334056.
- Limmer AL, Wu JH, Doan HQ, Rady PL, Tyring SK. Acquired epidermodysplasia verruciformis: a ten-year anniversary update. Br J Dermatol 182(3):790-792, 2020. e-Pub 2020. PMID: 31545504.
- Doan HQ, Hu MI, Goldstein J, Piha-Paul SA, Subbiah V, Patel AB. Vandetanib photoinduced cutaneous toxicities. Cutis 103(5):E24-E29, 2019. e-Pub 2019. PMID: 31233590.
- Narayanan D, Doan H, Simonette R, Rady PL, Tyring SK. Letter to the Editor in reference to: Expression of 15-lipoxygenase-1 in Merkel cell carcinoma is linked to advanced disease. Clin Otolaryngol 44(2):205-206, 2019. e-Pub 2019. PMID: 30367539.
- Wu JH, Simonette RA, Nguyen HP, Doan HQ, Rady PL, Tyring SK. Emerging differential roles of the pRb tumor suppressor in trichodysplasia spinulosa-associated polyomavirus and Merkel cell polyomavirus pathogeneses. J Clin Virol 76:40-3, 2016. e-Pub 2016. PMID: 26809132.
- Chattopadhyay A, Pinkaew D, Doan HQ, Jacob RB, Verma SK, Friedman H, Peterson AC, Kuyumcu-Martinez MN, McDougal OM, Fujise K. Fortilin potentiates the peroxidase activity of Peroxiredoxin-1 and protects against alcohol-induced liver damage in mice. Sci Rep 6:18701, 2016. e-Pub 2016. PMID: 26726832.
- Chattopadhyay A, Pinkaew D, Doan HQ, Jacob RB, Verma SK, Freidman H, Peterson AC, kuyumcu-Martinez MN, McDougal OM, and Fujise K. Fortilin potentiates the peroxidase activity of Peroxidredoxin-1 and protects against alcohol-induced liver damage in mice. Sci Rep 6:18701, 2016. e-Pub 2016.
- Nguyen HP, Doan HQ, Rady P, Tyring SK. Cellular signaling in sinecatechins-treated external genital and perianal warts; unraveling the mechanism of action of a botanical therapy. Virol Sin 30(3):214-7, 2015. e-Pub 2015. PMID: 25822119.
- Doan HQ, Nguyen HP, Rady P, Tyring SK. Expression Patterns of Immune-Associated Genes in External Genital and Perianal Warts Treated with Sinecatechins. Viral Immunol 28(4):236-40, 2015. e-Pub 2015. PMID: 25774455.
- Wu JH, Simonette RA, Hsiao T, Doan HQ, Rady PL, Tyring SK. Cutaneous Human Polyomavirus Small T Antigens and 4E-BP1 Targeting. Intervirology 58(6):382-5, 2015. e-Pub 2015. PMID: 27055259.
- Nguyen HP, Doan HQ, Brunell DJ, Rady P, Tyring SK. Apoptotic gene expression in sinecatechins-treated external genital and perianal warts. Viral Immunol 10(556-8):556-8, 2014. e-Pub 2014. PMID: 25275942.
- Ramirez-Fort MK, Doan HQ, Nguyen HP, Khan F, Kauffman J, Campbell LS. Chronic unilateral eruption of painful, erythematous papules and nodules. Piloleiomyoma. JAMA Dermatol 149(7):865-6, 2013. e-Pub 2013. PMID: 23636666.
- Doan HQ, Gulati N, Levis WR. Ingenol mebutate: potential for further development of cancer immunotherapy. J Drugs Dermatol 11(10):1156-7, 2012. e-Pub 2012. PMID: 23134979.
- Chen Y, Fujita T, Zhang D, Doan HQ, Pinkaew D, Liu Z, Wu J, Koide Y, Chiu A, Jun-Lin C, Chang JY, Ruan KH, Fujise K. The physical and functional antagonism between p53 and fortilin, an anti-apoptotic molecule. J Biol Chem 37(3275-85), 2011. e-Pub 2011.
- Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, Doan HQ, Weiss HL, Evers BM. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 210(5):767-76, 776-8, 2010. e-Pub 2010. PMID: 20421047.
- Bowen KA, Doan HQ, Zhou BP, Wang Q, Zhou Y, Rychahou PG, Evers BM. PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res 29(11):4439-49, 2009. e-Pub 2009. PMID: 20032390.
- Bowen KA, Silva SR, Johnson JN, Doan HQ, Jackson LN, Gulhati P, Qiu S, Riall TS, Evers BM. An analysis of trends and growth factor receptor expression of GI carcinoid tumors. J Gastrointest Surg 13(10):1773-80, 2009. e-Pub 2009. PMID: 19582519.
- Doan HQ, Bowen KA, Jackson LA, Evers BM. Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. Anticancer Res 29(7):2473-8, 2009. e-Pub 2009. PMID: 19596916.
- Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, Chung DH, Evers BM. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A 105(51):20315, 2008. e-Pub 2008. PMID: 19075230.
Invited Articles
- Doan HQ, Silapunt S, Migden MR. Sonedegib, a new Hedgehog pathway inhibitor for the treatment of advanced basal cell carcinoma in adults. Onco Targets Ther 9:5671-5678, 2016. e-Pub 2016.
- Doan HQ, Chinn GM, Jahan-Tigh RR. Flow Cytometry II: Mass and Imaging Cytometry. J Invest Dermatol 135(9):e36, 2015. e-Pub 2015.
- Doan HQ, Ung B, Ramirez-Fort MK, Khan F, Tyring SK. Zostavax a subcutaneous vaccine for the prevention of herpes zoster. Expert Opin Biol Ther 13(10):1467-7, 2013. e-Pub 2013. PMID: 23984934.
- Gordon R, Mays R, Doan HQ, Lapolla W, Tyring SK. Biologic therapy and risk of infection. Skin Therapy letter 17(4):1-4, 2012. e-Pub 2012.
- Chon SY, Doan HQ, Mays RM, Singh SM, Gordon RA, Tyring SK. Antibiotic overuse and resistance in dermatology. Dermatol Ther 25(1):55-59, 2012. e-Pub 2012. PMID: 22591499.
Review Articles
- Kukunoor, VD, Haff, PL, Black, TA, Farris, D, Nelson, KC, Doan, HQ. Dermoscopic features of nail unit melanoma. Clinical and Experimental Dermatology 51(8):1367-1375, 2026. e-Pub 2026. PMID: 41761708.
- Okwara, CJ, Black, TA, Haff, PL, Nammour, HM, Bassett Jr, R, Das, JA, Qian, JH, Schandua, HP, Teixeira, AJ, Gonna, N, Ahmad, AS, Okoro, CM, Farris, D, Nelson, KC, Doan, HQ. Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma. JAMA Dermatology 162(5):447-456, 2026. e-Pub 2026. PMID: 41811312.
- Okundia, F, Bouchelkia, I, Shakhashiro, M, Doan, HQ, Tyring, SK. Xanthogranuloma disseminatum. JAAD Case Reports 70:219-221, 2026. e-Pub 2026. PMID: 41859432.
- Duque-Clavijo, V, Doan, HQ, Tyring, SK. A Review of Cutaneous Viral Infections and Their Potential Role in Neurologic Diseases. Journal of Clinical Medicine 14(24), 2025. e-Pub 2025. PMID: 41464674.
- Nammour, HM, Madrigal, K, Starling, CT, Doan, HQ. Advancing Treatment Options for Merkel Cell Carcinoma. International journal of molecular sciences 25(20), 2024. e-Pub 2024. PMID: 39456853.
- Landes JR, Moore SA, Bartley BR, Doan HQ, Rady PL, Tyring SK. The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review. J Cancer Res Clin Oncol, 2023. e-Pub 2022. PMID: 35941226.
- Tran T, Rousseau MA, Farris DP, Bauer C, Nelson KC, Doan HQ. The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review. Cancer Causes Control 34(5):407-420, 2023. e-Pub 2023. PMID: 37027053.
- Tran T, Ternov NK, Weber J, Barata C, Berry EG, Doan HQ, Marghoob AA, Seiverling EV, Sinclair S, Stein JA, Stoos ER, Tolsgaard MG, Wolfensperger M, Braun RP, Nelson KC. Instructional Strategies to Enhance Dermoscopic Image Interpretation Education: a Review of the Literature. Dermatol Pract Concept 12(4):e2022189, 2022. e-Pub 2022. PMID: 36534542.
- Tran T, Ternov NK, Weber J, Barata C, Berry EG, Doan HQ, Marghoob AA, Seiverling EV, Sinclair S, Stein JA, Stoos ER, Tolsgaard MG, Wolfensperger M, Braun RP, Nelson KC. Theory-Based Approaches to Support Dermoscopic Image Interpretation Education: A Review of the Literature. Dermatol Pract Concept 12(4):e2022188, 2022. e-Pub 2022. PMID: 36534519.
- Chen OM, Kim K, Steele C, Wilmas KM, Aboul-Fettouh N, Burns C, Doan HQ, Silapunt S, Migden MR. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers (Basel) 14(15), 2022. e-Pub 2022. PMID: 35954384.
- Burns C, Kubicki S, Nguyen QB, Aboul-Fettouh N, Wilmas KM, Chen OM, Doan HQ, Silapunt S, Migden MR. Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers (Basel) 14(15), 2022. e-Pub 2022. PMID: 35954316.
- Gupta R, Rady PL, Doan HQ, Tyring SK. Development of a β-HPV vaccine: Updates on an emerging frontier of skin cancer prevention. J Clin Virol 126:104348, 2020. e-Pub 2020. PMID: 32334327.
- Doan HQ, Silapunt S, Migden MR. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. Onco Targets Ther 9:5671-5678, 2016. e-Pub 2016. PMID: 27695345.
- Ramirez-Fort MK, Downing C, Doan HQ, Benoist F, Oberste MS, Khan F, Tyring SK. Coxsackievirus A6 associated hand, foot, and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol 60(4):381-6, 2014. e-Pub 2014. PMID: 24932735.
Abstracts
- Bartley BR, Moore SA, Doan HQ, Rady PL, Tyring SK. Current treatments and emerging therapies of human polyomavirus-associated skin diseases: a comprehensive review. Int J Dermatol 62(3):387-396, 2023. e-Pub 2023. PMID: 36577746.
- Wu J, Limmer A, Doan H, Simonette R, Rady P, Tyring S. The novel AKT inhibitor afuresertib inhibits Merkel cell carcinoma through targeting TSC-mTOR and GSK-3 pathways. Journal of Investigative Dermatology 139(5):S21, 2019. e-Pub 2019.
- Wu J, Doan HQ, Simonette R, He Q, Rady P, Tyring SK. Modulation of elF4F complex assembly in Merkel cell carcinoma cells: Translational regulation of oncogenes and new therapeutic implications. J Invest Derm 137(5):S16, 2017. e-Pub 2017.
- Doan HQ, Simonette R, He Q, Rady P, Tyring SK. Gene expression analysis of Merkel Cell polyomavirus associated small-T antigen demonstrates metabolic pathway alterations. Journal of Investigative Dermatology 136(5, Supplement 1):S83, 2016. e-Pub 2016.
- Wu JH, Simonette R, Hsiao T, Doan HQ, Rady P, Tyring SK. Activation of cell signaling pathways in polyomavirus-meditated cutaneous carcinogenesis. J Invest Derm 136(5):S15, 2016. e-Pub 2016.
- Bowen KA, Zhou BP, doan HQ, Evers BM. Regulation of epithelial mesenchymal transition by PTEN in colorectal cancer. J AM Coll Surg 29(11):4439-4449, 2009. e-Pub 2009.
- Rychahou PG, Kang JH, Doan HQ, Chung DH, Evers BM. Concurrent mutation of PTEN and Arkt2 overexpression in colorectal cancer increases micrometastasis establishment and growth. Gastroenterology 105(51):20315-20320, 2008. e-Pub 2008.
- Silva SR, Chen LA, Doan HQ, Jr TC, Evers BM. The carcinoid cell line BON secretes factors that increase proliferation of human colonic and cardiac fibroblasts. Gasteroenterology 134, 2008. e-Pub 2008.
- Bowen KA, Zhou BP, Doan HQ, Chung DH, Evers BM. Upregulation of epithelial mesenchymal transition in colorectal cancer after PTEN knockdown 134(4):A-748, 2008. e-Pub 2008.
Book Chapters
- Gupta, R, Seervai, RN, Fu, S, Doan, HQ. Immunotherapies in non-melanoma skin cancers, 175-198, 2021.
- Doan HQ, Tucker SB. Local immunotherapy of basal cell carcinoma with interferon. In: Basal Cell Carcinoma: Advances in Treatment and Research. Springer Cham, 83-100, 2019.
- Doan HQ, Ramírez-Fort MK, Rady PL. Viral Oncogenesis. In: Human Papilloma Virus: Bench to Bedside. S Karger AG, 33-46, 2014.
- Doan HQ, Ramirez-Fort MK, Thompson A, Khan F, Tyring SK. Disorders of fat. In: Dermatology: A Pictorial Review, 2014.
Letters to the Editor
- Moore, SA, Landes, JR, Simonette, R, He, Q, Doan, HQ, Rady, PL, Tyring, SK. Selinexor targets expression of metabolic genes in Merkel cell carcinoma cells. Archives of Dermatological Research 316, 2024.
- Gupta, R, Roy, C, Doan, HQ. Assessing Participant Diversity in Acne Clinical Trials. Journal of Drugs in Dermatology 21: 797-798, 2022.
Patient Reviews
CV information above last modified August 26, 2026